These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2491259)

  • 21. Analysis of the int-1, int-2, c-myc, and neu oncogenes in human breast carcinomas.
    Meyers SL; O'Brien MT; Smith T; Dudley JP
    Cancer Res; 1990 Sep; 50(18):5911-8. PubMed ID: 1975511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4.
    Shackleford GM; MacArthur CA; Kwan HC; Varmus HE
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):740-4. PubMed ID: 8380647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of two homologous and clustered oncogenes, Hst1 and Int-2, during differentiation of F9 cells.
    Yoshida T; Muramatsu H; Muramatsu T; Sakamoto H; Katoh O; Sugimura T; Terada M
    Biochem Biophys Res Commun; 1988 Dec; 157(2):618-25. PubMed ID: 3060118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal variations among multiple primary mammary tumors and within a tumor of individual mice: insertion mutations of int oncogenes.
    Sarkar NH
    Virology; 1995 Oct; 212(2):490-9. PubMed ID: 7571419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.
    Morrison BW; Leder P
    Oncogene; 1994 Dec; 9(12):3417-26. PubMed ID: 7970700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequence analysis of the int-2/fgf-3 gene in aggressive human breast carcinomas.
    Meyers SL; Dudley JP
    Mol Carcinog; 1992; 6(4):243-51. PubMed ID: 1362493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The FGF-related oncogene, K-FGF, maps to human chromosome region 11q13, possibly near int-2.
    Huebner K; Ferrari AC; Delli Bovi P; Croce CM; Basilico C
    Oncogene Res; 1988; 3(3):263-70. PubMed ID: 3060803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoded protein.
    Yoshida T; Miyagawa K; Odagiri H; Sakamoto H; Little PF; Terada M; Sugimura T
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7305-9. PubMed ID: 2959959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
    Kitsberg DI; Leder P
    Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a MMTV insertion mutation within the coding region of the Fgf-3 protooncogene.
    Morris DW; Dutra JC
    Virology; 1997 Nov; 238(1):161-5. PubMed ID: 9375020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplification of the Int-2 gene in head and neck squamous cell carcinoma.
    Rubin JS; Qiu L; Etkind P
    J Laryngol Otol; 1995 Jan; 109(1):72-6. PubMed ID: 7876747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of both Wnt-1 and Fgf-3 by insertion of mouse mammary tumor virus downstream in the reverse orientation: a reappraisal of the enhancer insertion model.
    Clausse N; Baines D; Moore R; Brookes S; Dickson C; Peters G
    Virology; 1993 May; 194(1):157-65. PubMed ID: 8386870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NH2-terminal cleavage of xenopus fibroblast growth factor 3 is necessary for optimal biological activity and receptor binding.
    Antoine M; Daum M; Köhl R; Blecken V; Close MJ; Peters G; Kiefer P
    Cell Growth Differ; 2000 Nov; 11(11):593-605. PubMed ID: 11095248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection and characterization of the fibroblast growth factor-related oncoprotein INT-2.
    Dixon M; Deed R; Acland P; Moore R; Whyte A; Peters G; Dickson C
    Mol Cell Biol; 1989 Nov; 9(11):4896-902. PubMed ID: 2557543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A paradigm for oncogene complementation in human breast cancer.
    Roux-Dosseto M; Martin PM
    Res Virol; 1989; 140(6):571-91. PubMed ID: 2694252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCL-1 participates in the 11q13 amplification found in breast cancer.
    Theillet C; Adnane J; Szepetowski P; Simon MP; Jeanteur P; Birnbaum D; Gaudray P
    Oncogene; 1990 Jan; 5(1):147-9. PubMed ID: 2181375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors.
    Peters G; Brookes S; Smith R; Placzek M; Dickson C
    Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5678-82. PubMed ID: 2548184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
    Somers KD; Cartwright SL; Schechter GL
    Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The int genes in mouse mammary tumorigenesis and in normal development.
    Nusse R
    Ciba Found Symp; 1990; 150():212-22; discussion 222-6. PubMed ID: 2164908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA amplification of HER-2/neu and INT-2 oncogenes in epithelial ovarian cancer.
    Medl M; Sevelda P; Czerwenka K; Dobianer K; Hanak H; Hruza C; Klein M; Leodolter S; Müllauer-Ertl S; Rosen A
    Gynecol Oncol; 1995 Dec; 59(3):321-6. PubMed ID: 8522248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.